Immune regulation by CD4+CD25+ T cells and interleukin-10 in birch pollen-allergic patients and non-allergic controls

被引:48
作者
Thunberg, S.
Akdis, M.
Akdis, C. A.
Gronneberg, R.
Malmstrom, V.
Trollmo, C.
van Hage, M.
Gafvelin, G.
机构
[1] Karolinska Inst, Dept Med, Allergy & Clin Immunol Unit, Stockholm, Sweden
[2] Karolinska Inst, Dept Med, Div Resp Med, Stockholm, Sweden
[3] Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden
[4] Swiss Inst Allergy & Asthma Res, CH-7270 Davos, Switzerland
关键词
allergy; Bet v 1; CD4(+) 1 CD25(+) Treg; IL-10; influenza antigen; TNF-alpha;
D O I
10.1111/j.1365-2222.2007.02739.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
CD4(+)CD25(+) regulatory T (Treg) cells and the cytokines IL-10 or TGF-beta play key roles in the maintenance of T cell homeostasis and tolerance to infectious and non-infectious antigens such as allergens. To investigate the regulation of immune responses to birch pollen allergen compared with influenza antigen by Treg cells obtained from birch pollen-allergic patients and non-allergic controls. Peripheral blood was collected from 10 birch pollen-allergic patients and 10 non-allergic healthy controls. CD4(+)CD25(+) and CD4(+)CD25(-) cells isolated by magnetic-activated cell sorting were co-cultured and stimulated with birch pollen extract or influenza vaccine in the absence or presence of anti-IL-10 or soluble TGF-beta RII. CD4(+)CD25(+) cells from non-allergic controls were able to suppress influenza antigen and birch pollen stimulated effector cell proliferation, whereas CD4(+)CD25(+) cells from allergic patients suppressed influenza antigen-, but not birch pollen-stimulated proliferation. The production of Th1 cytokines, but not Th2 cytokines, was suppressed by CD4(+)CD25(+) cells from both allergic patients and controls, upon stimulation with birch pollen extract. Neutralization of IL-10 led to significantly increased production of IFN-gamma in cultures with CD4(+)CD25(-) T effector cells. In addition, six-fold higher concentrations of TNF-alpha were detected after neutralization of IL-10 in both CD4(+)CD25(-) and CD4(+)CD25(+) cell cultures from allergic patients and controls. We demonstrate that the allergen-specific suppressive function of CD4(+)CD25(+) cells from allergic patients is impaired compared with non-allergic controls. Moreover, neutralization of IL-10 enhances the production of TNF-alpha, suggesting counter-acting properties of IL-10 and TNF-alpha, where IL-10 promotes tolerance and suppression by Treg cells and TNF-alpha promotes inflammatory responses.
引用
收藏
页码:1127 / 1136
页数:10
相关论文
共 37 条
[1]   Role of interleukin 10 in specific immunotherapy [J].
Akdis, CA ;
Blesken, T ;
Akdis, M ;
Wüthrich, B ;
Blaser, K .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (01) :98-106
[2]   Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells [J].
Akdis, M ;
Verhagen, J ;
Taylor, A ;
Karamloo, F ;
Karagiannidis, C ;
Crameri, R ;
Thunberg, S ;
Deniz, G ;
Valenta, R ;
Fiebig, H ;
Kegel, C ;
Disch, R ;
Schmidt-Weber, CB ;
Blaser, K ;
Akdis, CA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (11) :1567-1575
[3]   CD25+CD4+ T cells compete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production [J].
Barthlott, T ;
Moncrieffe, H ;
Veldhoen, M ;
Atkins, CJ ;
Christensen, J ;
O'Garra, A ;
Stockinger, B .
INTERNATIONAL IMMUNOLOGY, 2005, 17 (03) :279-288
[4]   Regulatory activity of human CD4+ CD25+ T cells depends on allergen concentration, type of allergen and atopy status of the donor [J].
Bellinghausen, I ;
König, B ;
Böttcher, I ;
Knop, J ;
Saloga, J .
IMMUNOLOGY, 2005, 116 (01) :103-111
[5]   Evidence of a role of tumor necrosis factor α in refractory asthma [J].
Berry, MA ;
Hargadon, B ;
Shelley, M ;
Parker, D ;
Shaw, DE ;
Green, RH ;
Bradding, P ;
Brightling, CE ;
Wardlaw, AJ ;
Pavord, ID .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (07) :697-708
[6]   Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants [J].
Cobbold, SP ;
Castejon, R ;
Adams, E ;
Zelenika, D ;
Graca, L ;
Humm, S ;
Waldmann, H .
JOURNAL OF IMMUNOLOGY, 2004, 172 (10) :6003-6010
[7]   Th2 cells are less susceptible than Th1 cells to the suppressive activity of CD25+ regulatory thymocytes because of their responsiveness to different cytokines [J].
Cosmi, L ;
Liotta, F ;
Angeli, R ;
Mazzinghi, B ;
Santarlasci, V ;
Manetti, R ;
Lasagni, L ;
Vanini, V ;
Romagnani, P ;
Maggi, E ;
Annunziato, F ;
Romagnani, S .
BLOOD, 2004, 103 (08) :3117-3121
[8]   CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis [J].
de Kleer, IM ;
Wedderburn, LR ;
Taams, LS ;
Patel, A ;
Varsani, H ;
Klein, M ;
de Jager, W ;
Pugayung, G ;
Giannoni, F ;
Rijkers, G ;
Albani, S ;
Kuis, W ;
Prakken, B .
JOURNAL OF IMMUNOLOGY, 2004, 172 (10) :6435-6443
[9]   Evidence for a dual mechanism for IL-10 suppression of TNF-α production that does not involve inhibition of p38 mitogen-activated protein kinase or NF-κB in primary human macrophages [J].
Denys, A ;
Udalova, IA ;
Smith, C ;
Williams, LM ;
Ciesielski, CJ ;
Campbell, J ;
Andrews, C ;
Kwaitkowski, D ;
Foxwell, BMJ .
JOURNAL OF IMMUNOLOGY, 2002, 168 (10) :4837-4845
[10]   Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy [J].
Ehrenstein, MR ;
Evans, JG ;
Singh, A ;
Moore, S ;
Warnes, G ;
Isenberg, DA ;
Mauri, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (03) :277-285